These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20955728)

  • 1. Synthesis and in vitro evaluation of carboxymethyl starch-chitosan nanoparticles as drug delivery system to the colon.
    Saboktakin MR; Tabatabaie RM; Maharramov A; Ramazanov MA
    Int J Biol Macromol; 2011 Apr; 48(3):381-5. PubMed ID: 20955728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of chitosan hydrogels containing 5-aminosalicylic acid nanopendents for colon: specific drug delivery.
    Saboktakin MR; Tabatabaie RM; Maharramov A; Ramazanov MA
    J Pharm Sci; 2010 Dec; 99(12):4955-61. PubMed ID: 20821391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing chitosan-dextran sulfate nanoparticles using charge ratios.
    Chen Y; Mohanraj VJ; Wang F; Benson HA
    AAPS PharmSciTech; 2007 Nov; 8(4):E98. PubMed ID: 18181558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery.
    Calinescu C; Mateescu MA
    Eur J Pharm Biopharm; 2008 Oct; 70(2):582-9. PubMed ID: 18602991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of pH-dependent glycol chitosan and dextran sulfate nanoparticles for effective brain cancer treatment.
    Saboktakin MR; Tabatabaie RM; Maharramov A; Ramazanov MA
    Int J Biol Macromol; 2011 Nov; 49(4):747-51. PubMed ID: 21782844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
    Liu Z; Jiao Y; Liu F; Zhang Z
    J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
    Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
    Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro evaluation of thiolated chitosan--Poly(methacrylic acid) nanoparticles as a local mucoadhesive delivery system.
    Saboktakin MR; Tabatabaie RM; Maharramov A; Ramazanov MA
    Int J Biol Macromol; 2011 Apr; 48(3):403-7. PubMed ID: 21215774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
    Zambito Y; Di Colo G
    J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.
    Li P; Wang Y; Zeng F; Chen L; Peng Z; Kong LX
    Carbohydr Res; 2011 May; 346(6):801-6. PubMed ID: 21397214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
    Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
    Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quaternized chitosan (QCS)/poly (aspartic acid) nanoparticles as a protein drug-delivery system.
    Wang Tw; Xu Q; Wu Y; Zeng Aj; Li M; Gao H
    Carbohydr Res; 2009 May; 344(7):908-14. PubMed ID: 19303066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
    Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.
    Sahu SK; Maiti S; Maiti TK; Ghosh SK; Pramanik P
    J Drug Target; 2011 Feb; 19(2):104-13. PubMed ID: 20367067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication and evaluation of the novel reduction-sensitive starch nanoparticles for controlled drug release.
    Yang J; Huang Y; Gao C; Liu M; Zhang X
    Colloids Surf B Biointerfaces; 2014 Mar; 115():368-76. PubMed ID: 24463097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
    Lin CC; Lin CW
    Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiol-modified chitosan sulfate nanoparticles for protection and release of basic fibroblast growth factor.
    Ho YC; Wu SJ; Mi FL; Chiu YL; Yu SH; Panda N; Sung HW
    Bioconjug Chem; 2010 Jan; 21(1):28-38. PubMed ID: 20000719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-aggregated nanoparticles from linoleic acid modified carboxymethyl chitosan: Synthesis, characterization and application in vitro.
    Tan YL; Liu CG
    Colloids Surf B Biointerfaces; 2009 Mar; 69(2):178-82. PubMed ID: 19124228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro.
    Jeong YI; Jin SG; Kim IY; Pei J; Wen M; Jung TY; Moon KS; Jung S
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):149-55. PubMed ID: 20427160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.